Activez les alertes d’offres d’emploi par e-mail !
Mulipliez les invitations à des entretiens
Ein innovatives Unternehmen sucht einen Quality Assurance Engineer für spannende Projekte in der pharmazeutischen Industrie. In dieser Rolle sind Sie für die Validierung neuer Produktionslinien und die Gewährleistung der Einhaltung von GMP verantwortlich. Sie arbeiten eng mit verschiedenen Abteilungen zusammen und nutzen modernste Technologien wie automatisierte Fahrzeuge und Roboterreinigungssysteme. Dies ist eine großartige Gelegenheit, in einem dynamischen, multikulturellen Team zu arbeiten und zur Verdopplung der Produktionskapazität bis 2030 beizutragen. Wenn Sie eine Leidenschaft für Qualitätssicherung und innovative Technologien haben, ist dies die perfekte Chance für Sie!
Are you passionate about the pharmaceutical industry? Do you want to contribute to a global program involving multiple sites worldwide? Would you like to be part of a rapidly expanding company? If so, you might be the person we're looking for!
Our opportunity is based at the Chartres production site, which is undergoing a massive investment of 2.1 billion euros as part of a global program involving other sites worldwide.
As a Quality Assurance Engineer Validation Project, you will play a crucial role in ensuring the successful start-up of future production lines and associated equipment within specified timelines, adhering to Good Manufacturing Practices (GMP) and internal procedures.
You will have a cross-functional position, collaborating with various project departments such as aseptic production, finished product production, building and utilities, IT, warehouse and logistics, and quality control.
As an Engineer in Quality Assurance Project, your responsibilities will include :
In this role, you'll have the exciting opportunity to work on cutting-edge technologies, including :
As part of the “Fill and Finish Expansions” project, you will be connected to the Quality Assurance entity managing Novo Nordisk's entire investment project portfolio. You will play a key role in the extension project at the Chartres site, aiming to double production capacity by 2028-2030 to provide innovative treatments to an increasing number of patients.